Robert A. Dyer

Robert A. Dyer

Auto-generated profile, based on publicly available information

Robert A. Dyer

Department of Anaesthesia and Perioperative Medicine, University of Cape Town, South Africa

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2009 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
RDRobert A. Dyer
Robert A. Dyer
ARAnthony R. Reed
Anthony R. Reed
DDDominique van Dyk
Dominique van Dyk
MAMichelle J. Arcache
Michelle J. Arcache
OHOwen Hodges
Owen Hodges
MJMichael F. James
Michael F. James
Background: Hemodynamic responses to vasopressors used during spinal anesthesia for elective Cesarean delivery, have not been well described. This study compared the effects of bolus phenylephrine and ephedrine on maternal cardiac output (CO). The hypothesis was that phenylephrine, but not ephedrine, decreases CO when administered in response to hypotension during spinal anesthesia. Methods: Forty-three patients were randomized to receive 80 microg of phenylephrine or 10 mg of ephedrine. Both pulse wave form analysis and transthoracic bioimpedance changes were used to estimate stroke volume in each patient. Hemodynamic responses to spinal anesthesia and oxytocin were also recorded. A subgroup of 20 patients was randomized to receive oxytocin compared with oxytocin plus 80 microg of phenylephrine after delivery. Results: Mean CO and maximum absolute response in CO were significantly lower during the 150 s after phenylephrine administration than after ephedrine (6.2 vs. 8.1 l/min, P = 0.001, and 5.2 vs. 9.0 l/min, P < 0.0001, respectively for pulse wave form analysis, and 5.2 vs. 6.3 l/min, P = 0.01 and 4.5 vs. 6.7 l/min, P = 0.0001, respectively for bioimpedance changes). CO changes correlated with heart rate changes. Coadministration of phenylephrine obtunded oxytocin-induced decreases in systemic vascular resistance and increases in heart rate and CO. Trends in CO change were similar using either monitor. Conclusions: Bolus phenylephrine reduced maternal CO, and decreased CO when compared with ephedrine during elective spinal anesthesia for Cesarean delivery. CO changes correlated with heart rate changes after vasopressor administration, emphasizing the importance of heart rate as a surrogate indicator of CO. Coadministered phenylephrine obtunded hemodynamic responses to oxytocin.

1 May 2008 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
RDRobert A. Dyer
Robert A. Dyer
JPJenna L. Piercy
Jenna L. Piercy
ARAnthony R. Reed
Anthony R. Reed
CLCarl J. Lombard
Carl J. Lombard
LSLeann K. Schoeman
Leann K. Schoeman
MJMichael F. James
Michael F. James
ONLY since 1995, when the first randomized trial on the use of regional versus general anesthesia for cesarean delivery in severe preeclampsia was published,1 has spinal anesthesia (SA) been considered an option in this high-risk group of patients. As recently as 1998, an editorial recommended that epidural anesthesia is preferable to SA for cesarean delivery,2 even if the patient has not received epidural anesthesia in labor. Many recent studies suggest that SA is safe in the absence of contraindications to regional anesthesia.3–6 Some studies have shown less hypotension and lower vasopressor requirements than during SA in healthy parturients. One investigation found less hypotension during SA in severe preeclamptics than in preterm women in whom fetal weights were similar.4 This eliminated the possibility that the more minor degree of hypotension was due to a lesser degree of aortocaval compression in preeclamptic patients. Nevertheless, hypotension and placental underperfusion remain a risk,7 and SA may be associated with more neonatal acidosis than general anesthesia.8

1 June 2011 in Current Opinion in Anaesthesiology
Verified
Journal Article
Closed access
RDRobert A Dyer
Robert A Dyer
ABAlexander J Butwick
Alexander J Butwick
BCBrendan Carvalho
Brendan Carvalho
The implications of the obstetric use of oxytocin for obstetric anaesthesia practice are summarised. The review focuses on recent research on the uterotonic effects of oxytocin for prophylaxis and management of uterine atony during caesarean delivery. Oxytocin remains the first-line agent in the prevention and management of uterine atony. In-vitro and in-vivo studies show that prior exposure to oxytocin induces uterine muscle oxytocin receptor desensitization. This may influence oxytocin dosing for adequate uterine tone following delivery. Oxytocin has important cardiovascular side-effects (hypotension, tachycardia and myocardial ischaemia). Recent studies suggest that the effective dose of oxytocin for prophylaxis against uterine atony during caesarean delivery is significantly lower than the 5-10 IU historically used by anaesthesiologists. Slow administration of small bolus doses of oxytocin minimises maternal haemodynamic disturbance. Continuous oxytocin infusions are recommended for maintaining uterine tone after bolus administration, although ideal infusion rates are still to be established. The efficacy of the long-acting oxytocin analogue carbetocin requires further investigation. Recommendations are presented for oxytocin dosing during caesarean delivery. Oxytocin remains the first-line uterotonic after vaginal and caesarean delivery. Recent research elucidates the therapeutic range of oxytocin during caesarean delivery, as well as receptor desensitization. Evidenced-based protocols for the prevention and treatment of uterine atony during caesarean delivery are recommended.

1 July 2010 in International Journal of Obstetric Anesthesia
Verified
Journal Article
Closed access
RDR.A. Dyer
R.A. Dyer
DDD. van Dyk
D. van Dyk
ADA. Dresner
A. Dresner

1 February 2018 in International Journal of Obstetric Anesthesia
Verified
Journal Article
Closed access
RDR.A. Dyer
R.A. Dyer
AEA. Emmanuel
A. Emmanuel
SAS.C. Adams
S.C. Adams
CLC.J. Lombard
C.J. Lombard
MAM.J. Arcache
M.J. Arcache
DDD. van Dyk
D. van Dyk

1 November 2010 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
RDRobert A. Dyer
Robert A. Dyer
ARAnthony R. Reed
Anthony R. Reed